BAY 1142524
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY 1142524, covering 2019-09-03 to 2019-09-03. Get the full timeline:
Most recent: Clinical Trial Update: A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY 1142524 in Patients After Acute Myocardial Infarction With Left-ventricular Dysfunction [Phase 2]